Sinopharm
1099.HK
#1978
Rank
NZ$14.59 B
Marketcap
$4.68
Share price
0.24%
Change (1 day)
8.70%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

EPS for Sinopharm (1099.HK)

EPS in 2022: $0.70

According to Sinopharm's latest financial reports the company's current EPS (TTM) is $0.70. In 2022 the company made an earnings per share (EPS) of $0.70 an increase over its 2021 EPS that were of $0.69.

EPS history for Sinopharm from 2006 to 2022

Annual EPS

Year EPS Change
2022$0.701.3%
2021$0.6910.33%
2020$0.6317.26%
2019$0.545.44%
2018$0.51-0.87%
2017$0.5119.44%
2016$0.4315.3%
2015$0.3717.06%
2014$0.3221.9%
2013$0.2611.82%
2012$0.2325.24%
2011$0.1931.02%
2010$0.143.3%
2009$0.1446.85%
2008$0.0937267.57%
2007$0.05593310.24%
2006$0.01363